A collaborative study to establish the second national standard for hepatitis B immunoglobulin in Korea

• Published in: Biologicals 2023-05, Vol.82, p.101679-101679, Article 101679
• Main Authors: Choi, Chan Woong, Seong, Su Kyoung, Han, Ki Won, Kim, Hyun Jeong, Sohn, Kyung Hee, Shim, Sun Bo, Bang, Yun Su, Cho, JungHwan, Shin, In Soo
• Format: Article
• Language: English
• Subjects: Collaborative study; Enzyme immunoassay; Hepatitis B immunoglobulin; Immunoglobulins; International Cooperation; National standard; Reference Standards; Republic of Korea
• ISSN: 1045-1056; 1095-8320
• DOI: 10.1016/j.biologicals.2023.101679

This study aimed to establish a second national standard for hepatitis B immunoglobulin (HBIG) that can be used for potency assays of hepatitis B and normal immunoglobulin. The candidate material was manufactured using a process approved as Good Manufacturing Practice. The freeze-dried candidate preparation was tested for physicochemical and biological properties, including pH, residual moisture, molecular size distribution, and potency. A collaborative study was performed involving four laboratories, including the National Institute of Food and Drug Safety Evaluation, as an official national control laboratory in Korea and manufacturers. The potency was calibrated against the second international standard for HBIG using two enzyme immunoassays: enzyme-linked immunosorbent assay and electrochemiluminescence immunoassay. Results from 240 assays were obtained from four laboratories, and combined potency estimates were obtained by calculating the geometric means. Intra- and inter-laboratory variability showed acceptable geometric coefficients of variation of 1.3–6.0 and 3.2–3.6%, respectively. The candidate preparation showed satisfactory stability in accelerated thermal degradation and real-time stability tests. Based on these results, the potency value of 105 IU/vial was assigned (95% confidence intervals: 100.0–109.2 IU/vial), and it was deemed suitable to serve as the Korean national standard for HBIG. •The potency was calibrated against the second international standard for HBIG.•The candidate preparation showed satisfactory stability.•The potency value of 105 IU/vial was assigned.